Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Goldman Sachs, Bank of America, JP Morgan, Netflix, J&J, Producer Prices, and More to Watch This Week
02:00pm, Sunday, 12'th Apr 2026
Big Banks kick off first-quarter earnings, but we'll also hear from Abbot Labs, PepsiCo, ASML, and more. And we'll see economic data on producer prices, housing, and the mood among small businesses.
Wall Street Week Ahead
06:47am, Sunday, 12'th Apr 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
BIP Wealth LLC Acquires 3,899 Shares of Johnson & Johnson $JNJ
04:42am, Sunday, 12'th Apr 2026
BIP Wealth LLC grew its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 35.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14
History Says the Best Time to Buy Stocks May Be Imminent
03:45am, Sunday, 12'th Apr 2026
The best time to buy stocks may be closer than you think -- and history has the receipts.
Addenda Capital Inc. Trims Stock Position in Johnson & Johnson $JNJ
03:14am, Sunday, 12'th Apr 2026
Addenda Capital Inc. cut its stake in shares of Johnson and Johnson (NYSE: JNJ) by 9.8% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Co
Better Buy Right Now: Johnson & Johnson Vs. Pfizer
01:00am, Sunday, 12'th Apr 2026
Johnson & Johnson is one of the largest pharmaceutical stocks by market cap. Pfizer's dividend offers a hefty yield.
The $100 Billion Pivot: Why Johnson & Johnson Is My Top Dividend King to Buy in 2026
11:30am, Saturday, 11'th Apr 2026
Johnson & Johnson is facing lawsuits, patent cliffs, and disruptive drug pricing negotiations. Despite that, the company's revenue continues to grow and should top $100 billion this year.
Stocks Rallied After President Donald Trump's Ceasefire in Iran. Here's How to Invest Now.
05:06am, Saturday, 11'th Apr 2026
The war in Iran has weighed on investors' minds, so the ceasefire was welcome news. All three major indexes climbed more than 2.5% in the trading session following Trump's announcement.
Johnson & Johnson Q1 Earnings Preview: Time To Sell The Rally?
08:45am, Friday, 10'th Apr 2026
Johnson & Johnson stock is up 17% YTD and over 60% in the past twelve months, reflecting renewed investor confidence but also raising concerns about the sustainability of the rally. In this update on
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson showcases new clinical data for TECNIS PureSee IOL demonstrating excellent contrast sensitivity and extended range of vision.
Could Buying This Dividend Pharma Stock Today Set You Up for Life?
08:15pm, Thursday, 09'th Apr 2026
Johnson & Johnson has an incredible dividend-increase streak spanning more than 60 years. The company's business is diversified beyond drugs, providing more avenues for growth and increased business s
Should You Buy, Sell or Hold JNJ Stock Ahead of Q1 Earnings?
11:47am, Thursday, 09'th Apr 2026
JNJ approaches Q1 results with strong drug growth and MedTech momentum. However, rising biosimilar competition and pricing pressures cloud the outlook.
Gear Up for Johnson & Johnson (JNJ) Q1 Earnings: Wall Street Estimates for Key Metrics
10:15am, Thursday, 09'th Apr 2026
Besides Wall Street's top-and-bottom-line estimates for Johnson & Johnson (JNJ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared durin
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
07:57am, Thursday, 09'th Apr 2026
Johnson & Johnson (NYSE: JNJ) will release earnings for its first quarter before the opening bell on Tuesday, April 14.
Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know
06:46pm, Wednesday, 08'th Apr 2026
Johnson & Johnson (JNJ) closed at $241.3 in the latest trading session, marking a +1.21% move from the prior day.
